The immobilization of basic fibroblast growth factor on plasma-treated poly(lactide-co-glycolide)
Source abstract
Abstract
In this study, possibility of the method of immobilization of basic fibroblast growth factor (bFGF) on polylactone-type polymer scaffolds via plasma treatment was investigated. To introduce acid carboxylic functional groups on the surface of the polymer matrix, poly(lactide-co-glycolide) (PLGA) film was treated with carbon dioxide (CO2) plasma and then incubated in a phosphate buffer saline (PBS, pH 7.4) solution of bFGF. The bFGF binding efficiency to the CO2 plasma-treated PLGA (PT-PLGA) films under different treating parameters was investigated and compared. It was found bFGF binding efficiency to PLGA was enhanced by CO2 plasma treatment. The binding efficiency of bFGF to PLGA was variational with CO2 plasma treating time and it reached a maximum after a treating time of 20min under the power of 20W. The changes of surface chemistry and surface topography induced by CO2 plasma treatment played main roles in improving binding efficiency. Bound bFGF was released continuously from the films for up to 7 days in vitro. The stability of bFGF immobilized on PLGA film via CO2 plasma treatment was tested further under dynamic conditions by a Parallel Plate Flow Chamber. Mouse 3T3 fibroblasts were cultured on the bFGF bound PLGA with a prior plasma treatment (20W, 20min) (PT-PLGA/bFGF) film, which showed that bFGF released from PT-PLGA/bFGF film was bioactive. Adhesion and growth of cells on PLGA scaffolds were greatly improved by immobilization of bFGF on them. Therefore, the method of CO2 plasma treatment combining bFGF anchorage not only was usable in delivering bFGF, but also could be applied extensively for surface modification of scaffolds in tissue engineering.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Periodontal Regeneration and Treatments · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Fibroblast growth factor-210.1016/S1357-2725(99)00123-5 ↗
2. Biological roles of fibroblast growth factor-2
3. Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities10.1016/S0142-9612(99)00121-0 ↗
4. Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel10.1016/S0142-9612(03)00557-X ↗
5. Intrapericardial delivery of fibroblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia10.1016/S0022-3565(24)35353-4 ↗
6. Ultrastructural immunolocalization of basic fibroblast growth factor in fibroblasts and extracellular matrix10.1007/s004180050442 ↗
7. Proliferation of endothelial cells on surface-immobilized albumin-heparin conjugate loaded with basic fibroblast growth factor10.1002/(SICI)1097-4636(19990305)44:3<330::AID-JBM12>3.0.CO;2-O ↗
8. Randomized placebo-controlled trial of use of topical recombinant bovine basic fibroblast growth factor for second-degree burns10.1016/S0140-6736(98)01260-4 ↗
9. Accelerating effects of basic fibroblast growth factor on wound healing of rat palatal mucosa10.1016/j.joms.2003.05.007 ↗
10. Potential role of fibroblast growth factor in enhancement of fracture healing10.1097/00003086-199810001-00029 ↗
11. Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: result of a Phase I open-label dose escalation study10.1016/S0735-1097(00)00988-8 ↗
12. Growth factor delivery in tissue engineering10.1557/S0883769400031870 ↗
13. A formulation method using d,l-lactic acid oligomer for protein release with reduced initial burst10.1016/0168-3659(93)90070-L ↗
14. Polypeptide growth factors: targeted delivery systems10.1016/S0142-9612(97)00050-1 ↗
15. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres10.1002/jbm.a.10542 ↗
16. Growth factor delivery for tissue engineering10.1023/A:1007502828372 ↗
17. Materials for protein delivery in tissue engineering10.1016/S0169-409X(98)00021-0 ↗
18. In vivo cellular repopulation of tubular elastin scaffolds mediated by basic fibroblast growth factor10.1016/j.biomaterials.2007.02.031 ↗
19. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF10.1016/j.biomaterials.2006.05.018 ↗
20. Osteochondral repair using the combination of fibroblast growth factor and amorphous calcium phosphate/poly(l-lactic acid) hybrid materials10.1016/j.biomaterials.2007.03.017 ↗
21. Covalently immobilized gradients of bFGF on hydrogel scaffolds for directly cell migration10.1016/j.biomaterials.2004.09.021 ↗
22. Surface modification of interconnected porous scaffolds10.1002/jbm.a.30367 ↗
23. Effects of EGF and bFGF on irradiated parotid glands10.1007/s10956-005-1853-z ↗
24. Acceleration effect of basic fibroblast growth factor on the regeneration of peripheral nerve through a 15-mm gap10.1002/jbm.a.10008 ↗
25. Cartilage tissue engineering PLLA scaffold with surface immobilized collagen and basic fibroblast growth factor10.1016/j.biomaterials.2004.04.031 ↗
26. Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery10.1007/s11095-006-9039-9 ↗
27. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(l-lactide-co-glycolide) nanospheres and fibrin gel10.1016/j.biomaterials.2005.08.030 ↗
28. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor10.1002/jbm.a.30843 ↗
29. Plasma treatments and plasma deposition of polymers for biomedical applications10.1016/S0257-8972(97)00285-5 ↗
30. Acid and basic functionalities of nitrogen and carbon dioxide plasma-treated polystyrene10.1002/sia.2029 ↗
31. Characterization of surface property of poly(lactide-co-glycolide) after oxygen plasma treatment10.1016/j.biomaterials.2003.11.051 ↗
32. Promotion of cell affinity of porous PLLA scaffolds by immobilization of RGD peptides via plasma treatment10.1002/mabi.200500130 ↗
33. Enhanced cell affinity of poly (d,l-lactide) by combining plasma treatment with collagen anchorage10.1016/S0142-9612(01)00400-8 ↗
34. Combining oxygen plasma treatment with anchorage of cationized gelatin for enhancing cell affinity of poly(lactide-co-glycolide)10.1016/j.biomaterials.2007.06.004 ↗
35. Modulating bone cells response onto starch-based biomaterials by surface plasma treatment and protein adsorption10.1016/j.biomaterials.2006.09.010 ↗
36. Improvement of cell adhesion on poly(l-lactide) by atmospheric plasma treatment10.1002/jbm.a.30521 ↗
37. Plasma-treated, collagen-anchored polylactone: its cell affinity evaluation under shear or shear-free conditions10.1002/jbm.a.10034 ↗
38. Cell adhesion on gaseous plasma modified poly-(l-lactide) surface under shear stress field10.1016/S0142-9612(03)00251-5 ↗
39. Biodegradable polymers for use in surgery-polyglycolic/polyactic acid homo and copolymers10.1016/0032-3861(79)90009-0 ↗
40. The fabrication and characterization of poly(lactic acid) scaffolds for tissue engineering by improved solid–liquid phase separation10.1002/pat.370 ↗
41. Role of plasma protein adsorption in the response of blood to foreign surfaces
42. Energetic characterization of the basic fibroblast growth factor-heparin interaction: Identification of the heparin binding domain10.1021/bi00179a006 ↗
43. An in vitro study of flow response by cells10.1016/0021-9290(71)90013-3 ↗
44. An apparatus to study the response of cultured endothelium to shear stress10.1115/1.3138624 ↗
45. Influences of ammonia plasma treatment on modifying depth and degradation of poly(l-lactide) scaffolds10.1016/j.biomaterials.2005.12.007 ↗